公开(公告)号：EP4371569A1

公开(公告)日：2024-05-22

申请号：EP22383104.1

申请日：2022-11-16

申请人： Universidad del País Vasco/Euskal Herriko Unibertsitatea

发明人： BAÑUELOS RODRÍGUEZ, Sonia ,  GUÉRIN AGUILAR, Diego Marcelo

IPC分类号： A61K39/00 ,  A61K39/385 ,  C07K14/005 ,  C07K14/47 ,  C07K14/82 ,  C12N7/04 ,  C12N15/866

CPC分类号： A61K39/0011 ,  A61K2039/80420180801 ,  A61K39/385 ,  A61K2039/607520130101 ,  A61K2039/58520130101 ,  C07K14/47 ,  C07K2319/73520130101 ,  C07K14/82 ,  C12N2770/2205220130101 ,  C12N2770/2202220130101 ,  C12N2770/2202320130101 ,  C12N2770/2204220130101 ,  C12N2710/1414320130101 ,  C12N2710/1414420130101 ,  C12N15/866 ,  C12N2800/4020130101 ,  C07K14/005 ,  C12N7/045

摘要： The present invention belongs to the field of human therapies as it proposes the use of a viral capsid as antigen carrier for making vaccines. The invention involves the design of virus-like particles (VLPs) comprising an acute myeloid leukaemia (AML)-specific antigen and the process for their production.